source
- Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in MyelofibrosisAndrew Kuykendall, MD, explains considerations for JAK inhibitor sequencing and the use of transplant in myelofibrosis.onclive · 3mo ago↗ source
- New Endometrial Targets Beyond HER2Interest in endometrial cancer extends well beyond HER2, and the faculty review a growing pipeline of antibody drug conjugates directed at additional targets. Discussion includes why TROPE2 and oth…onclive · 3mo ago↗ source
- Coordinating Care in Multiple Myeloma Across Practice Settingsonclive · 3mo ago↗ source